India to Brazil: Cabozantinib Export Trade Route

The India to Brazil Cabozantinib corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $5.9K USD. The route is dominated by VAMA LIFECARE PRIVATE LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's cabozantinib manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $534 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 11.4%, placing it at rank #9 among India's top cabozantinib export destinations globally.

On the import side, key buyers of Indian cabozantinib in Brazil include TO THE, EDMUNDO MARCEDO DE ALBUQUERQUE, `TO THE ORDER OF and 6 others. TO THE is the single largest importer with 3 shipments valued at $1.8K USD.

India's cabozantinib exports to Brazil are driven primarily by a handful of large-scale manufacturers. VAMA LIFECARE PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VAMA LIFECARE PRIVATE LIMITED, SPECIALITY MEDICINES LIMITED, WELLNESS PHARMA INTERNATIONAL — together account for 93% of total trade value on this route. The average shipment value of $534 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical medicines for human use - cabozantinib tablets 20 mg and harmless medicine for human consumptioncabozantinib tablets 60mg brand name cazanat 60mg batch no po240694a, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE is the largest importer with 3 shipments worth $1.8K USD — representing 31% of all cabozantinib imports from India on this route. A total of 9 buyers are active on this corridor.